edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Molecure
Molecure — 2 videos in collection
Molecure is a clinical-stage biotechnology company. It uses its medicinal chemistry and biology capabilities to discover and develop first-in-class small molecule drug candidates that directly modulate underexplored protein targets and the function of RNA designed to treat multiple incurable diseases. Molecure has two lead assets in clinical trials: OATD-01 (a chitotriosidase inhibitor) in a Phase II study for the treatment of sarcoidosis, and OATD-02 (an ARG1/2 inhibitor) in a Phase I study for patients with advanced and/or metastatic solid tumours.
In this video, Samson Fung, Molecure’s Chief Medical Officer, provides background on the clinical investigation of the company’s developmental pipeline.
Get access to the very latest content matched to your personal investment style.